+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 1Year - 5Years
All Genders
Healthy Volunteers
ID05934669

Comparison of Intranasal Midazolam, Dexmedetomidine, and Ketamine for Pediatric Anxiety and Discharge Time During Minor Procedures in the Emergency Department

Led by University of Oklahoma · Updated on 2024-06-28

90

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the use of three intranasal medicationsMidazolam, Dexmedetomidine, and Ketamineto improve anxiety relief and reduce emergency department stay times during minor procedures in young children aged 1 to 5 years. The study aims to identify which medication provides the shortest stay and highest satisfaction for patients and providers. This research is important because pain in young children is often under-recognized due to their limited ability to describe it, and improving medication options could enhance care quality and family experience. The study compares three drugs delivered through the nose to avoid needles and provide quick absorption Midazolam, a common sedative with some side effects Dexmedetomidine, which mimics sleep and is often preferred for children with behavioral concerns and Ketamine, which provides both sedation and pain relief. Each medication is given based on the childs weight, and participants are randomly assigned to receive one of the three. Dosages vary per medication, with Midazolam and Ketamine doses capped at 10mg and 100mg respectively, and Dexmedetomidine capped at 100mcg. The study uses a masked design, so neither the patient nor providers know which drug is given. Participants will be monitored during their emergency department visit as the research team measures the time it takes from medication administration to discharge. They will also assess the childs anxiety using a validated scale and gather satisfaction ratings from both parents and physicians. The study is expected to run until mid-2025, with all procedures and assessments completed on the day of treatment. This approach helps evaluate which medication best balances quick recovery and positive experiences for children undergoing minor procedures.

CONDITIONS

Brief Title

IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric ED

Research Team

G

Gavely Toor, DO

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here